- Home
- APLM vs ADGM Comparison
APLM vs ADGM Comparison
Compare APLM & ADGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLM
- ADGM
- Stock Information
- Founded
- APLM 2016
- ADGM 2011
- Country
- APLM United States
- ADGM United States
- Employees
- APLM N/A
- ADGM N/A
- Industry
- APLM Blank Checks
- ADGM
- Sector
- APLM Finance
- ADGM
- Exchange
- APLM Nasdaq
- ADGM NYSE
- Market Cap
- APLM 12.3M
- ADGM 12.7M
- IPO Year
- APLM N/A
- ADGM N/A
- Fundamental
- Price
- APLM $9.56
- ADGM $0.77
- Analyst Decision
- APLM Strong Buy
- ADGM
- Analyst Count
- APLM 2
- ADGM 0
- Target Price
- APLM $425.00
- ADGM N/A
- AVG Volume (30 Days)
- APLM 36.2K
- ADGM 1.2M
- Earning Date
- APLM 02-15-2025
- ADGM 02-15-2025
- Dividend Yield
- APLM N/A
- ADGM N/A
- EPS Growth
- APLM N/A
- ADGM N/A
- EPS
- APLM N/A
- ADGM N/A
- Revenue
- APLM $2,101,000.00
- ADGM $543,000.00
- Revenue This Year
- APLM N/A
- ADGM N/A
- Revenue Next Year
- APLM N/A
- ADGM N/A
- P/E Ratio
- APLM N/A
- ADGM N/A
- Revenue Growth
- APLM 70.54
- ADGM 187.30
- 52 Week Low
- APLM $6.50
- ADGM $0.75
- 52 Week High
- APLM $91.00
- ADGM $9.34
- Technical
- Relative Strength Index (RSI)
- APLM 46.48
- ADGM N/A
- Support Level
- APLM $9.50
- ADGM N/A
- Resistance Level
- APLM $10.67
- ADGM N/A
- Average True Range (ATR)
- APLM 0.92
- ADGM 0.00
- MACD
- APLM -0.04
- ADGM 0.00
- Stochastic Oscillator
- APLM 13.17
- ADGM 0.00
About APLM Apollomics Inc.
Apollomics Inc is an innovative clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company lead programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other advanced tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.
About ADGM ADAGIO MEDICAL HOLDINGS INC
Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for treatment of cardiac arrhythmias. The company focuses on developing innovative cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia.